Oncological pathology
- Number of publications
- 547
Publications
-
Jan van Weelden W; Reijnen C; Küsters-Vandevelde HVN; Bulten J; Bult P; Leung S; Visser NCM; Santacana M; Bronsert P; Hirschfeld M; Colas E; Gil-Moreno A; Reques A; Mancebo G; Huvila J; Koskas M; Weinberger V; Bednarikova M; Hausnerova J; Snijders MPLM; Matias-Guiu X; Amant F; Krakstad C; van de Vijver K; McAlpine J; Pijnenborg J; ENITEC-consortium
The cut-off for estrogen and progesterone receptor in endometrial cancer revisited: an ENITEC collaboration study.
HUMAN PATHOLOGY 109 80-91. .
-
Frias-Gomez J; Peremiquel-Trillas P; Alemany L; Ameijide A; Marcos-Gragera R; Ponce J; Brunet J; Matias-Guiu X; Galceran J; Izquierdo Á; Borràs JM; Costas L; Clèries R
Predicting the rising incidence and mortality of endometrial cancers among women aged 65-74 years in Catalonia.
MATURITAS 144 11-15. .
-
Concin N; Creutzberg CL; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann JA; Bosse T; Chargari C; Fagotti A; Fotopoulou C; González-Martín A; Lax SF; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell DE; Querleu D; Raspollini MR; Sehouli J; Sturdza AE; Taylor A; Westermann AM; Wimberger P; Colombo N; Planchamp F; Matias-Guiu X
ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.
VIRCHOWS ARCHIV 478 153-190. .
-
Murillo, SM; Cudos, AG; Subirats, OP; Olive, JM; Morales, CC; Villellas, FV; Guzman, DRS; Rodriguez, JV; Galindo, AR
Axillary management after neoadjuvant chemotherapy in initially node positive early breast cancer
CANCER RESEARCH 81 -. .
-
Cudos, AG; Murillo, SM; Subirats, OP; Villellas, FV; Guzman, DRS; Morales, CC; Olive, JM; Sanchez, AV; Ortega, JFC
Relapse pattern after neoadjuvant treatment in early breast cancer
ANNALS OF ONCOLOGY 32 437-437. .
-
Concin N; Matias-Guiu X; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann J; Bosse T; Chargari C; Fagotti A; Fotopoulou C; Gonzalez Martin A; Lax S; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell D; Querleu D; Raspollini MR; Sehouli J; Sturdza A; Taylor A; Westermann A; Wimberger P; Colombo N; Planchamp F; Creutzberg CL
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 31 12-39. .
-
Ojanguren A; Santamaría M; Milla-Collado L; Fraile C; Gatius-Calderó S; Puy S; Boldó A; Gómez-Olles S; Boada-Pérez M; Esquinas C; Sáez-Giménez B; Ojanguren I; Barrecheguren M; Olsina-Kissler JJ
Pilot Trial of Extended Hypothermic Lung Preservation to Analyze Ischemia-reperfusion Injury in Pigs.
ARCHIVOS DE BRONCONEUMOLOGIA 57 479-489. .
-
Nicolas-Sanchez, FJ; Arostegui-Gorospe, JI; Pallares-Quixal, J; Nicolas-Sarrat, FJ; Sarrat-Nuevo, RM; Bou, RMN; Melgarejo-Moreno, PJ
p.RQ92 mutation associated with amyloidosis
REUMATOLOGIA CLINICA 17 46-48. .
-
MATIAS-GUIU GUIA, XAVIER
Endometrial Cancer Histopathology Reporting Guide
Endometrial Cancer Histopathology Reporting Guide -. .
-
Romero I; Rubio MJ; Medina M; Matias-Guiu X; Santacana M; Schoenenberger JA; Guerra EM; Cortés A; Minig L; Coronado P; Cueva JF; Gómez L; Malfettone A; Sampayo M; Llombart-Cussac A; Poveda A
An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study.
GYNECOLOGIC ONCOLOGY 159 721-731. .
-
Miller RE; Leary A; Scott CL; Serra V; Lord CJ; Bowtell D; Chang DK; Garsed DW; Jonkers J; Ledermann JA; Nik-Zainal S; Ray-Coquard I; Shah SP; Matias-Guiu X; Swisher EM; Yates LR
ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer.
ANNALS OF ONCOLOGY 31 1606-1622. .
-
Mellid S; Coloma J; Calsina B; Monteagudo M; Roldán-Romero JM; Santos M; Leandro-García LJ; Lanillos J; Martínez-Montes ÁM; Rodríguez-Antona C; Montero-Conde C; Martínez-López J; Ayala R; Matias-Guiu X; Robledo M; Cascón A
Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma.
Cancers 12 1-12. .